Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Nextleaf Solutions Ltd.

A pioneering force in the cannabis industry, driving innovation in extraction and life science technology.

 

Bullboard - Investor Discussion Forum Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Nextleaf Solutions Ltd. is a cannabis processor with a portfolio of federally regulated emerging consumer brands, market validated cannabis derivative products, and high-potency bulk ingredients. The Company’s multi-patented, highly automated, closed loop extraction, and distillation technology sets the global standard for processing cannabis at scale. The Company manufactures over 80 different... see more

CSE:OILS - Post Discussion

View:
Post by Gotime2 on May 20, 2021 11:07am

Valens

Valens is up $.20 today. that's the equivalent of the entire market capitalization of nextleaf. Just on news of distribution of their product line into New Brunswick retail stores. Hard to believe nextleaf gets so little love, it was big news when they announced the launch of house branded vape products And no movement in the stock price.
They can't ignore us forever. Management keeps executing, making the right moves in the right direction. I'm looking forward to the day our share price will regularly move $.20 on not spectacular news.
I think this time next year
Comment by stealthct on May 20, 2021 11:17am
I posted once about the last financials from Valens. Extremely impressive how they pivoted away from extraction full-time. They are penetrating new markets both large, medium and small. Getting the product right into consumers. Exceptional cash on hand.  As the country recovers, they will do exceptionally well.  Happy to see thriving cananbis companies like Valens and Terascend. Canada ...more  
Comment by zazouranapak on May 20, 2021 3:50pm
Contracts and product development and products on shelfs valens is 2 years ahead of us but that's where Nextleaf is going yes its been long but it's not like the compnay is failing or closing its doors it's actually excelling at evrything they are working on you'll see  patents value wen they are validated by top line revenue which assume will start in q2 bump from 1.2mto ...more  
Comment by Gotime2 on May 20, 2021 5:41pm
I agree with all your predictions except the Q2 revenues. I think will be waiting till Q1 or Q2 next year before we see $4.5m. I hope you are right, and I am wrong, but with low expectations I will not be disappointed. The waiting game continues.
Comment by Salbrom on May 21, 2021 9:45am
Next Year.... for what 4.5 million all the contracts CBD gummies vapes no one will wait for 4.5 million next year they will crash it to 0.10
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with C.OILS


Investor Presentation

View the Presentation

Investment Opportunity

  • Market Leadership with patented extraction and distillation technology offering significant efficiencies and higher purity levels over competing technologies
     
  • Debt free and four consecutive years of positive gross revenue. Reported fiscal YE 2023 gross revenue of $9.96MM with a gross profit of $2.3MM
     
  • Untapped domestic growth across various market segments, and the ability to scale production without additional capital expenditure
     
  • Backed by 19 U.S. patents and over 75 global patents provides a solid foundation for future growth and potential licensing opportunities

Nextleaf Solutions Ltd. With CEO, Emma Andrews

Primary Extraction

Distillation

Manufacturing: Softgels

The Vault

Facebook